Carlos R Figueiredo Selected Research

Carlos R Figueiredo Research Topics

Disease

24	Neoplasms (Cancer) 12/2023 - 11/2011
24	Melanoma (Melanoma, Malignant) 12/2023 - 11/2011
4	Neoplasm Metastasis (Metastasis) 01/2020 - 04/2012
3	Uveal melanoma 01/2023 - 01/2020
3	Carcinoma (Carcinomatosis) 04/2018 - 10/2012
3	Leukemia 07/2015 - 10/2012
2	Wilms Tumor (Wilm's Tumor) 12/2014 - 01/2014
2	Experimental Melanoma 04/2014 - 01/2012
2	Adenocarcinoma 02/2013 - 10/2012
1	Hypoxia (Hypoxemia) 01/2023
1	Monosomy 01/2023
1	Adenocarcinoma of Lung 08/2016
1	Blister (Bulla) 07/2015
1	Multiple Sclerosis 07/2013
1	Ulcer 10/2012
1	Arthritis (Polyarthritis) 10/2012
1	Rheumatic Diseases (Rheumatism) 10/2012
1	Diarrhea 10/2012
1	Leprosy (Hansen's Disease) 10/2012
1	Gout 10/2012
1	Wounds and Injuries (Trauma) 10/2012
1	Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated) 07/2011

Drug/Important Bio-Agent (IBA)

13	Peptides (Polypeptides)IBA 12/2023 - 11/2011
5	Complementarity Determining Regions (Complementarity Determining Region)IBA 12/2023 - 04/2012
5	Volatile Oils (Essential Oils)IBA 04/2018 - 10/2012
5	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2016 - 01/2012
4	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2020
4	Proteins (Proteins, Gene)FDA Link 01/2023 - 11/2011
3	ChromatinIBA 11/2017 - 04/2014
3	DNA (Deoxyribonucleic Acid)IBA 11/2017 - 06/2015
2	Immunoglobulins (Immunoglobulin)IBA 01/2019 - 09/2014
2	Caspase 3 (Caspase-3)IBA 01/2019 - 11/2015
2	germacrene DIBA 04/2018 - 02/2013
2	LignansIBA 08/2017 - 07/2015
2	Antineoplastic Agents (Antineoplastics)IBA 11/2016 - 01/2014
2	Petroleum (Crude Oil)IBA 11/2015 - 02/2013
2	AcidsIBA 09/2015 - 01/2014
2	PhosphatidylserinesIBA 07/2015 - 04/2014
2	AntibodiesIBA 12/2014 - 09/2014
2	Transcription Factors (Transcription Factor)IBA 12/2014 - 01/2014
1	gomesinIBA 12/2023
1	RNA (Ribonucleic Acid)IBA 01/2023
1	Perilipin-2IBA 01/2023
1	Carvedilol (Coreg)FDA LinkGeneric 01/2023
1	LipidsIBA 01/2023
1	Oxygen (Dioxygen)IBA 01/2023
1	Adrenergic Receptors (Adrenergic Receptor)IBA 01/2023
1	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 01/2023
1	RetinoidsIBA 01/2023
1	Adrenergic Agents (Adrenergic Drugs)IBA 01/2023
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2023
1	Immune Checkpoint InhibitorsIBA 01/2020
1	Hydroxyl RadicalIBA 01/2020
1	Carrier Proteins (Binding Protein)IBA 01/2019
1	Caspase 9IBA 01/2019
1	AntigensIBA 01/2019
1	Conditioned Culture MediaIBA 01/2019
1	Cyclic PeptidesIBA 01/2019
1	Indicators and Reagents (Reagents)IBA 01/2019
1	Phosphates (Orthophosphate)IBA 01/2019
1	chamigreneIBA 04/2018
1	caryophylleneIBA 04/2018
1	Terpenes (Terpenoids)IBA 11/2017
1	Benzene (Benzole)IBA 08/2017
1	dehydrodieugenol BIBA 08/2017
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 11/2016
1	Actins (F Actin)IBA 01/2016
1	CalreticulinIBA 11/2015
1	Monoterpenes (Monoterpenoids)IBA 11/2015
1	HMGB1 Protein (HMG1)IBA 11/2015
1	campheneIBA 11/2015
1	mastoparanIBA 06/2015
1	FITC-annexin A5IBA 06/2015
1	ZincIBA 12/2014
1	HeptanesIBA 04/2014
1	octacosaneIBA 04/2014
1	HydrocarbonsIBA 04/2014
1	Arginine (L-Arginine)FDA Link 01/2014
1	Lysine (L-Lysine)FDA Link 01/2014
1	GalactosidasesIBA 01/2014
1	Fingolimod Hydrochloride (FTY720)FDA Link 07/2013
1	CateninsIBA 07/2013
1	OxidesIBA 10/2012
1	pinaneIBA 10/2012
1	AmidesIBA 04/2012
1	Monoclonal AntibodiesIBA 04/2012
1	p38 Mitogen-Activated Protein KinasesIBA 01/2012
1	QuinonesIBA 01/2012
1	jacaranoneIBA 01/2012
1	quinone (benzoquinone)IBA 01/2012
1	Peptide LibraryIBA 11/2011
1	N-desmethylpheniramineIBA 07/2011
1	tesmilifene (DPPE)IBA 07/2011

Therapy/Procedure

11	Therapeutics 12/2023 - 11/2011
4	Immunotherapy 01/2023 - 01/2018
2	Traditional Medicine (Folk Remedies) 08/2013 - 10/2012
2	Drug Therapy (Chemotherapy) 07/2013 - 07/2011